Biomarkers | Pediatric Fungal Network STudy of Rare Invasive Fungal DisEases

Skip to main content

Search

Join Our Contact Registry

Header Social Media

Our Research
Patients and Families
- Patient Advocacy Groups
- Glossary
Researchers & Clinicians
- Funding Opportunities
- Collaborate With Us
Early Stage Investigators
News and Events
- Latest News
- Upcoming Events
About Us

An NIH-Funded Rare Diseases Clinical Research Network Consortium

Biomarker testing involves detecting molecules that indicate a fungal pathogen is present (e.g. Cryptococcal antigen).

Footer menu

Web Policies
Rare Diseases Clinical Research Network
Genetic and Rare Diseases Information Center
Members Login
Contact Us
Sitemap

The Pediatric Fungal Network STudy of Rare Invasive Fungal DisEases in Immunocompromised Pediatric Patients (PFN-STRIDE) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). PFN-STRIDE is funded under grant number U54AI198184 as a collaboration between NCATS, the National Institute of Allergy and Infectious Diseases (NIAID), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS) under grant number TR002818. The content of this website is solely the responsibility of the PFN-STRIDE administrative coordinating center at Children's Hospital of Philadelphia and does not necessarily represent the official views of the NIH.

social media